Core Viewpoint - Global Medical REIT Inc. announces the retirement of Ronald Marston from its Board of Directors and declares dividends for the fourth quarter of 2025 for both common and preferred stocks [1][2][3]. Board of Directors - Ronald Marston has been an independent director since 2015 and has held various leadership roles, including chair of the Nominating and Corporate Governance Committee [2]. - His retirement will take effect at the end of his current term, concluding at the Company's Annual Meeting of Stockholders in 2026 [2]. Dividends - The Board declared a cash dividend of $0.75 per share for the fourth quarter of 2025, payable on January 9, 2026, to stockholders of record as of December 19, 2025 [3]. - A quarterly cash dividend of $0.46875 per share on Series A Cumulative Redeemable Preferred Stock will be payable on February 2, 2026, to stockholders of record as of January 15, 2026 [4]. - A quarterly cash dividend of $0.388 per share on Series B Cumulative Redeemable Preferred Stock will also be payable on February 2, 2026, to stockholders of record as of January 15, 2026 [5]. Company Overview - Global Medical REIT Inc. is a net-lease medical REIT that acquires healthcare facilities and leases them to physician groups and healthcare systems [7].

Core Viewpoint - Global Medical REIT Inc. has announced a proposed public offering of its Series B Cumulative Redeemable Preferred Stock, aiming to utilize the net proceeds for general corporate purposes, including funding new acquisitions and repaying debt [1][3]. Offering Details - The offering will include a 30-day option for underwriters to purchase additional shares to cover over-allotments [1]. - The Series B Preferred Stock is intended to be listed on the New York Stock Exchange under the ticker symbol "GMRE-PrB" [2]. - The offering is made under the company's shelf registration statement, which was declared effective by the SEC on April 4, 2024 [3]. Use of Proceeds - The net proceeds from the offering are expected to be used for general corporate purposes, which may include funding new acquisitions and repaying existing indebtedness [1]. Company Overview - Global Medical REIT Inc. operates as a net-lease medical REIT, acquiring healthcare facilities and leasing them to physician groups and healthcare systems [5].

Core Points - Global Medical REIT Inc. has announced a public offering of its Series B Cumulative Redeemable Preferred Stock, subject to market conditions [1][2] - The company plans to use the net proceeds from this offering for general corporate purposes, which may include funding new acquisitions and repaying existing debt [1] - The Series B Preferred Stock is expected to be listed on the New York Stock Exchange under the ticker symbol "GMRE-PrB" [2] Offering Details - The offering is being conducted under the company's shelf registration statement, which was declared effective by the SEC on April 4, 2024 [3] - The underwriters will have a 30-day option to purchase additional shares to cover over-allotments [1] - Book-running managers for the offering include Raymond James, BMO Capital Markets, Stifel, and Baird [2] Company Overview - Global Medical REIT Inc. operates as a net-lease medical REIT, acquiring healthcare facilities and leasing them to physician groups and healthcare systems [5]